Impact Factor
2.4
2023-24

ABOUT CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Cancer Biotherapy and Radiopharmaceuticals is a peer-reviewed journal covering cutting-edge biotherapy and innovative investigations of methods to improve cancer therapy. Includes more selective delivery of drugs, biologicals, radiopharmaceuticals, or other agents, and advances in delivery instrumentation and technology, with the aim of increasing efficacy of therapy and/or decreasing toxicity or improving convenience of therapy. Topics include: • Pre-targeted cancer therapy • Clinical trials in cancer research • Antibody therapy and imaging • Tumor cell vaccines • Radioimmunotherapy • T-cell therapy • Molecular targeted therapy and imaging • Drug resistance

Legend

  • 1084-9785
  • Biochemistry, Genetics and Molecular Biology,Medicine,Pharmacology, Toxicology and Pharmaceutics
  • 1996-ongoing
  • United States

METRICS

YEAR Impact Factor
2023-24 2.4
2022 3.4
2021 3.632

DETAILS

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1084-9785, 1996-ongoing, Biochemistry, Genetics and Molecular Biology,Medicine,Pharmacology, Toxicology and Pharmaceutics.

Directory Indexing of International Research Journals